Super-relaxed myosins contribute to respiratory muscle hibernation in mechanically ventilated patients
Marloes van den Berg,Zhonghua Shi,Wout J Claassen,Pleuni Hooijman,Christopher T A Lewis,Jesper L Andersen,Robbert J van der Pijl,Sylvia J P Bogaards,Stefan Conijn,Eva L Peters,Leon P L Begthel,Bas Uijterwijk,Johan Lindqvist,Paul R Langlais,Armand R J Girbes,Sandra Stapel,Henk Granzier,Kenneth S Campbell,Weikang Ma,Thomas Irving,Darren T Hwee,James J Hartman,Fady I Malik,Marinus Paul,Albertus Beishuizen,Julien Ochala,Leo Heunks,Coen A C Ottenheijm
DOI: https://doi.org/10.1126/scitranslmed.adg3894
2024-07-31
Abstract:Patients receiving mechanical ventilation in the intensive care unit (ICU) frequently develop contractile weakness of the diaphragm. Consequently, they may experience difficulty weaning from mechanical ventilation, which increases mortality and poses a high economic burden. Because of a lack of knowledge regarding the molecular changes in the diaphragm, no treatment is currently available to improve diaphragm contractility. We compared diaphragm biopsies from ventilated ICU patients (N = 54) to those of non-ICU patients undergoing thoracic surgery (N = 27). By integrating data from myofiber force measurements, x-ray diffraction experiments, and biochemical assays with clinical data, we found that in myofibers isolated from the diaphragm of ventilated ICU patients, myosin is trapped in an energy-sparing, super-relaxed state, which impairs the binding of myosin to actin during diaphragm contraction. Studies on quadriceps biopsies of ICU patients and on the diaphragm of previously healthy mechanically ventilated rats suggested that the super-relaxed myosins are specific to the diaphragm and not a result of critical illness. Exposing slow- and fast-twitch myofibers isolated from the diaphragm biopsies to small-molecule compounds activating troponin restored contractile force in vitro. These findings support the continued development of drugs that target sarcomere proteins to increase the calcium sensitivity of myofibers for the treatment of ICU-acquired diaphragm weakness.